| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 38.016 | 75.959 | 71.241 | 62.369 | 60.775 | 136.367 | 135.622 | 98.347 | 131.063 | 171.161 |
| Total Income - EUR | 38.274 | 76.104 | 71.340 | 68.204 | 60.933 | 136.636 | 136.496 | 98.423 | 133.555 | 172.293 |
| Total Expenses - EUR | 40.091 | 70.767 | 65.210 | 60.921 | 69.995 | 122.295 | 129.679 | 97.787 | 127.405 | 171.520 |
| Gross Profit/Loss - EUR | -1.817 | 5.336 | 6.130 | 7.283 | -9.062 | 14.341 | 6.817 | 636 | 6.150 | 774 |
| Net Profit/Loss - EUR | -1.817 | 3.817 | 4.683 | 6.602 | -9.670 | 12.977 | 5.461 | -335 | 4.842 | -3.586 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 |
Check the financial reports for the company - Ambermed Invest Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 17.613 | 17.612 | 17.926 | 16.109 | 16.838 | 17.236 | 16.006 | 15.055 | 15.917 | 32.042 |
| Current Assets | 106.020 | 112.849 | 106.448 | 104.476 | 99.464 | 140.429 | 141.542 | 134.657 | 106.581 | 160.960 |
| Inventories | 34.876 | 34.204 | 39.826 | 41.301 | 40.825 | 50.275 | 51.214 | 49.189 | 42.059 | 62.951 |
| Receivables | 49.109 | 55.876 | 40.024 | 32.995 | 35.050 | 65.617 | 62.925 | 61.508 | 58.406 | 88.573 |
| Cash | 22.035 | 22.769 | 26.599 | 30.181 | 23.588 | 24.538 | 27.403 | 23.960 | 6.116 | 9.435 |
| Shareholders Funds | 44.847 | 48.207 | 52.074 | 57.720 | 39.551 | 51.778 | 56.091 | 49.846 | 24.212 | 3.403 |
| Social Capital | 49 | 49 | 48 | 47 | 46 | 45 | 44 | 45 | 44 | 44 |
| Debts | 78.801 | 82.254 | 72.300 | 62.865 | 77.096 | 105.921 | 101.458 | 100.144 | 98.285 | 189.603 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4774 - 4774" | |||||||||
| CAEN Financial Year |
4774
|
|||||||||
Comments - Ambermed Invest Srl